Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma Read more about Therapeutic Targeting Of CSN5, A Negative Regulator Of P53 And P27, In Human Hepatocellular Carcinoma US Application 13/551,580Filed on 2012-07-17
Cancer Immunotherapy by Delivering Class II MHC Antigens Using A VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using A VLP-Replicon US Application 15/104,785Filed on 2016-06-15
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Japan2016-558546Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon European Patent14824680.4Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Canada2934075Filed on 2014-12-16
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Read more about Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon Australia2014365777Filed on 2014-12-16
Aza-Epoxy-Guaiane Derivatives and Treatment of Cancer Read more about Aza-Epoxy-Guaiane Derivatives and Treatment of Cancer US Patent 9,676,788Filed on 2015-02-05
Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer Read more about Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer European Patent15705869.4Filed on 2015-02-05
Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer Read more about Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer Canada2938971Filed on 2015-02-05
Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer Read more about Aza-Epoxy-Guaiane Derivatives And Treatment of Cancer Australia2015214189Filed on 2015-02-05